2.38
Proqr Therapeutics N V Aktie (PRQR) Neueste Nachrichten
ProQR Therapeutics (PRQR) Receives "Buy" Rating from Chardan Cap - GuruFocus
Earnings visualization tools for ProQR Therapeutics N.V.Share Buyback & Daily Volume Surge Trade Alerts - newser.com
Will ProQR Therapeutics N.V. (0PQ) stock enhance shareholder valueJuly 2025 Short Interest & Proven Capital Preservation Methods - newser.com
Is ProQR Therapeutics N.V. stock a good choice for value investors2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Regression analysis insights on ProQR Therapeutics N.V. performanceGlobal Markets & Fast Gain Stock Tips - newser.com
Can ProQR Therapeutics N.V. (0PQ) stock ride next bull market cycle2025 Stock Rankings & High Yield Equity Trading Tips - newser.com
Pattern recognition hints at ProQR Therapeutics N.V. upside2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com
Using Bollinger Bands to evaluate ProQR Therapeutics N.V.July 2025 Fed Impact & Growth Focused Entry Point Reports - newser.com
Why ProQR Therapeutics N.V. is moving todayTreasury Yields & Fast Entry High Yield Stock Tips - newser.com
Will ProQR Therapeutics N.V. stock outperform international peersRate Cut & Weekly Breakout Watchlists - newser.com
What’s the recovery path for long term holders of ProQR Therapeutics N.V.2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
Key metrics from ProQR Therapeutics N.V.’s quarterly dataEarnings Recap Report & Smart Money Movement Tracker - newser.com
ProQR Advances AX-0810 into Clinical Trials for Cholestatic Diseases - TipRanks
Transcript : ProQR Therapeutics N.V.Shareholder/Analyst Call - MarketScreener
How ProQR Therapeutics N.V. (0PQ) stock compares with tech leadersJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Custom watchlist performance reports with ProQR Therapeutics N.V.Weekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Is ProQR Therapeutics N.V. stock cheap at current valuationOptions Play & Expert-Curated Trade Recommendations - newser.com
Does ProQR Therapeutics N.V. stock trade at a discount to peers - newser.com
Will ProQR Therapeutics N.V. stock gain from government policiesMarket Volume Report & Stock Timing and Entry Methods - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 80.2% in October - Defense World
Is ProQR Therapeutics N.V. stock attractive for growth ETFsMarket Movers & Weekly Consistent Profit Watchlists - newser.com
Why analysts recommend ProQR Therapeutics N.V. (0PQ) stockQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
What catalysts could drive ProQR Therapeutics N.V. stock higherWeekly Loss Report & Consistent Return Strategy Ideas - newser.com
How sentiment analysis helps forecast ProQR Therapeutics N.V.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Update - MarketBeat
ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Visualizing ProQR Therapeutics N.V. stock with heatmapsTrade Entry Summary & Long Hold Capital Preservation Tips - newser.com
ProQR Therapeutics NV expected to post a loss of 10 cents a shareEarnings Preview - TradingView
ProQR Therapeutics (PRQR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Is ProQR Therapeutics N.V. (0PQ) stock at risk of policy regulation2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):